ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 164

The Prevalence of Gout in a Large Tertiary Hospital and the Impact of in-Hospital Attacks of Acute Gout On Patient Outcomes and Health Resource Utilisation – a Nested Case-Control Study

John HY Moi1, Mark Tacey2, Carol Roberts3, Caroline Brand2, Alexandra Gorelik3 and Sharon Van Doornum2, 1Department of Rheumatology, Department of Medicine (RMH), The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia, 2Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia, 3Melbourne EpiCentre, The Royal Melbourne Hospital, Melbourne, Australia

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods and gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Acute gout can develop in hospitalised patients either as a new event or as a recurrence of established disease. To date there have been no studies examining the effect of in-hospital acute gout on hospital length of stay (LOS) or health resource utilisation. This study was performed to investigate the burden of gout in a hospitalised population and to assess the impact of acute gout on patient outcomes and health resource utilisation.

Methods: The study utilised hospital administrative data from The Royal Melbourne Hospital, Victoria over a ten year period (1 January 2001 to 31 December 2010).  Gout was defined according to The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM) codes and subdivided into three categories: ‘P-gout’ (gout was the primary reason for admission or was a pre-existing condition requiring treatment initiation/adjustment during admission), ‘C-gout’ (gout occurred as a complication during hospitalisation and was not a pre-existing condition), or ‘A-gout’ (gout was an associated diagnosis and did not require specific treatment during admission). The overall burden of gout was measured by determining the prevalence of gout diagnoses affecting all hospital admissions (excluding day case admissions) over the study period. The effect of acute gout on patient outcomes and health resource utilisation was measured in a nested case control study with matching of ‘C-gout’ patients to controls (ratio of 1:5) by age, gender, and principal diagnosis. Outcome measures included LOS, 28-day hospital readmission rates, and total number of hospital days in the 12 months post hospital discharge. For comparisons between ‘C-gout’ and matched control cases, the student T-test or Wilcoxon ranksum test for continuous data and Chi2test for categorical data were used. A p-value of <0.05 was considered significant. 

Results: There were 278,491 multi-day hospital admission episodes during the 10 year study period. Of these, 1,400 (0.5%) had an ICD-10-AM code for gout (‘P-gout’=1,058, ‘C-gout’=307 and ‘A-gout’=35). A steady increase in the annual burden of gout of 0.22% over 10 years was noted. Patients who experienced an in-hospital attack of acute gout had a substantially longer LOS than the controls (median 13 days (IQR 7-25) vs. 5 days (IQR 2-11), p<0.001) and also had higher readmission rates in the first 28-days (p=0.002) and during the first 12 months (p<0.001) of hospital discharge.

Conclusion: Our study demonstrates a growing burden of in-hospital gout attacks and increased utilisation of health resources in patients who experience acute gout as a complication of their hospital stay. It was not possible from the design of our study to exclude other potential confounding factors which may have contributed to the observed increased hospital LOS.


Disclosure:

J. H. Moi,
None;

M. Tacey,
None;

C. Roberts,
None;

C. Brand,
None;

A. Gorelik,
None;

S. Van Doornum,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalence-of-gout-in-a-large-tertiary-hospital-and-the-impact-of-in-hospital-attacks-of-acute-gout-on-patient-outcomes-and-health-resource-utilisation-a-nested-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology